News

XRP Faces Key Support Test as Price Dips Below $2.40

XRP Faces Key Support Test as Price Dips Below $2.40

XRP Faces Crucial Support as Price Declines

XRP (CRYPTO: XRP) has experienced a notable decrease of 4%, trading at approximately $2.39. This drop has traders anxious about the possibility of a critical breakdown beneath the $2.30 mark. Such a move could signify a more profound retracement, threatening to undo gains accumulated over recent months.

Technical Analysis Indicates Potential Further Losses

The current situation is highlighted by XRP's breach of a long-standing symmetrical triangle, which defined its price range since midsummer. Unfortunately, the token has not managed to bounce back from the 20-day and 50-day exponential moving averages, both currently situated between $2.55 and $2.72. This reversal indicates a negative momentum trend, suggesting that buyers are starting to lose steam after repeated attempts to stabilize within the $2.30–$2.40 range.

The daily Relative Strength Index (RSI) is resting at 38, reinforcing the notion of weak momentum and minimal follow-through during price rebounds. Unless the RSI can break higher towards the neutral 50 level, it seems unlikely that the oversold conditions will lead to a meaningful recovery.

Investor Behavior Shifts: Whale Activity Decreases

Recent on-chain data indicates a shift in investment behavior, reflecting an ongoing trend of net outflows from exchanges. Investors appear to be moving their tokens back to exchanges rather than accumulating more. For instance, recent reports showed $7.43 million in outflows recorded as XRP hovered around the $2.39 price point.

As the latter half of the month has unfolded, trading activity has notably quieted, lacking significant inflow spikes to counterbalance selling pressure. This decline in whale and institutional accumulation starkly contrasts the mid-summer period characterized by increasing inflow volumes, which supported subsequent relief rallies.

Key Levels to Monitor for XRP Price Movements

Looking at immediate resistance points, we find that the first key level lies at $2.55, corresponding to the 20-day EMA. Following this, resistance can be found around $2.61 and $2.75 at the 200-day and 50-day EMAs, respectively. For bulls to regain control, a decisive daily close above this clustered zone would be necessary to restore a neutral trading outlook.

Conversely, if XRP falls below the crucial $2.30 support area, we could see price targets shift towards $1.90 and $1.60. These levels coincide with liquidity gaps and the lower thresholds of broader market structures, indicating potentially significant areas of support for traders to watch closely.

Frequently Asked Questions

1. What happened to XRP's price recently?

XRP's price recently dropped by 4%, declining to around $2.39 due to concerns over support levels.

2. Why is the $2.30 level significant for XRP?

The $2.30 level is crucial as it represents the final support before a deeper price retracement may occur.

3. What does the current RSI indicate for XRP?

The RSI is currently at 38, suggesting weak momentum and limited potential for upward price movements at this time.

4. How has investor behavior changed regarding XRP?

Investors are demonstrating signs of moving tokens back to exchanges instead of accumulating, resulting in persistent net outflows.

5. What technical levels should traders watch for XRP?

Traders should pay attention to immediate resistance around $2.55, with support levels at $2.30, $1.90, and $1.60 being crucial for future price movement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Heritage Commerce Corp Welcomes New Board Member Christopher Abate

Updated Category News Views 237

Heritage Commerce Corp Expands Board with New Addition Heritage Commerce Corp (NASDAQ: HTBK), the parent company of Heritage Bank of Commerce, recently celebrated the expansion of its Board of Directors with the appointment of Christopher J. Abate. This marks an important milestone as the Board now comprises nine directors, increasing from the previous eight. Welcoming a...

Continue Reading
North American Construction Group's 2024 Year-End Financial Report

Updated Category News Views 266

North American Construction Group Ltd. Reports Year-End Results North American Construction Group Ltd. (TSX:NOA/NYSE:NOA) has reported its financial results for the fourth quarter and the whole year of 2024. The company continues to showcase significant revenues while navigating challenges in equipment utilization and market demands. Overall, the figures presented in...

Continue Reading
Cycurion Secures Major Contract to Enhance Emergency Networks

Updated Category News Views 139

Cycurion's New Contract Highlights Commitment to Modernization Cybersecurity and IT services company Cycurion, Inc. (NASDAQ: CYCU) recently announced a significant achievement with its latest contract. The company has partnered with a leading telecommunications provider for a vital initiative aimed at modernizing emergency warning networks for one of the federal...

Continue Reading
Maxeon Solar Technologies Reports Financial Insights for 2025

Updated Category News Views 312

Maxeon Solar Technologies' Revenue Decline The financial results for the first half of 2025 revealed a revenue of $39 million for Maxeon Solar Technologies. Strategic Shift Amid Industry Challenges Facing continued pressure from market conditions, Maxeon is undergoing significant business transformation aimed at enhancing fiscal discipline. CEO Commentary on CBP...

Continue Reading
Reading International Excels with Impressive 2024 Holiday Box Office

Updated Category News Views 183

Reading International Reports Record-Breaking Holiday Ticket Sales Reading International, Inc. (NASDAQ: RDI), a prominent player in the cinema and real estate industries, has made a remarkable announcement regarding its holiday box office results for 2024. With entertainment fast becoming an essential part of our culture, Reading has successfully leveraged the release of...

Continue Reading